1. The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM);Bajinka;Arch. Physiol. Biochem,2023
2. Schisandrin B, a potential GLP-1R agonist, exerts anti-diabetic effects by stimulating insulin secretion;Shang;Mol. Cell Endocrinol.,2023
3. Efficacy and safety of tirzepatide in type 2 diabetes and obesity management;Sinha;J. Obes. Metab. Syndr.,2023
4. GLP-1 receptor agonists: beyond their pancreatic effects;Zhao;Front Endocrinol. (Lausanne),2021
5. Novel small molecule glucagon-like peptide-1 receptor agonist S6 stimulates insulin secretion from rat islets;Yang;Front Pharm.,2021